Results for "Quercetin Senolytic" in Diabetes

20 articles

SGLT2 Inhibitors May Slow Aging by Clearing Senescent Cells
Metabolic Health

SGLT2 Inhibitors May Slow Aging by Clearing Senescent Cells

Diabetes drugs like empagliflozin show surprising anti-aging effects — mimicking caloric restriction and reducing senescent cell burden.

Research Paper
May 15, 2026 0
Cytochrome c Protein Blocks Ferroptosis Cell Death Linked to Aging and Disease
Metabolic Health

Cytochrome c Protein Blocks Ferroptosis Cell Death Linked to Aging and Disease

New research reveals how a key cellular protein prevents ferroptosis, a type of cell death implicated in aging and age-related diseases.

Research Paper
Mar 29, 2026 3
New Skincare Protocol Combats GLP-1 Weight Loss Drug Side Effects on Facial Aging
Metabolic Health

New Skincare Protocol Combats GLP-1 Weight Loss Drug Side Effects on Facial Aging

Flavo-Proxylane topical treatment plus ultrasound reduced skin laxity by 44% in people using weight loss medications.

Research Paper
Mar 28, 2026 3
Marine Compound Enterocin Lowers Cholesterol by Targeting Liver Protein ASGR1
Metabolic Health

Marine Compound Enterocin Lowers Cholesterol by Targeting Liver Protein ASGR1

Natural polyketide from marine bacteria enhances cholesterol removal and improves fat metabolism in liver cells and mice.

Research Paper
Mar 29, 2026 2
Scientists Map How Cholesterol Controls Cell Growth Through mTOR Pathway
Metabolic Health

Scientists Map How Cholesterol Controls Cell Growth Through mTOR Pathway

New cryo-EM structures reveal how LYCHOS protein senses cholesterol levels to regulate mTORC1 signaling, offering drug targets for aging.

Research Paper
Apr 5, 2026 0
New Injectable Drug Cuts Cholesterol 28% in Teens With Genetic High Cholesterol
Metabolic Health

New Injectable Drug Cuts Cholesterol 28% in Teens With Genetic High Cholesterol

Inclisiran safely reduced LDL cholesterol by 28% in adolescents with familial hypercholesterolemia, offering hope for early intervention.

Research Paper
Mar 29, 2026 0
Anthocyanin Supplements Reverse Prediabetes in 56% of Participants Within 12 Weeks
Metabolic Health

Anthocyanin Supplements Reverse Prediabetes in 56% of Participants Within 12 Weeks

Daily anthocyanin supplementation helped over half of prediabetic participants return to normal glucose tolerance in just 12 weeks.

Research Paper
Mar 28, 2026 3
Natural Compound Salvianolic Acid C Activates Kidney-Protective Mitophagy Pathway in Diabetes
Metabolic Health

Natural Compound Salvianolic Acid C Activates Kidney-Protective Mitophagy Pathway in Diabetes

A new ESRRA-ATG5 axis links mitochondrial recycling to arginine metabolism, and a plant polyphenol activates it to protect diabetic kidneys.

Research Paper
Jun 3, 2026 0
Finerenone Slows Kidney Decline in Non-Diabetic CKD Patients
Metabolic Health

Finerenone Slows Kidney Decline in Non-Diabetic CKD Patients

A landmark RCT shows finerenone reduces eGFR decline and kidney-cardiovascular events in CKD patients without diabetes.

Research Paper
Jun 8, 2026 0
New Dual-Target Drug Amycretin Achieves 24% Weight Loss in Clinical Trials
Metabolic Health

New Dual-Target Drug Amycretin Achieves 24% Weight Loss in Clinical Trials

Novel obesity drug targeting two pathways simultaneously shows unprecedented weight loss results in recent clinical studies.

Research Paper
Mar 28, 2026 1
Steroid Hormone GPR56 Axis Shields the Liver from Ferroptosis
Metabolic Health

Steroid Hormone GPR56 Axis Shields the Liver from Ferroptosis

A steroid hormone activates receptor GPR56 to block ferroptosis, a form of iron-driven cell death linked to liver disease.

Research Paper
Apr 22, 2026 0
Nanoplastics Accumulate in Mouse Testes and Trigger Sperm-Killing Ferroptosis via CISD1
Metabolic Health

Nanoplastics Accumulate in Mouse Testes and Trigger Sperm-Killing Ferroptosis via CISD1

50 nm polystyrene nanoplastics accumulate in mouse testes, degrading sperm quality and triggering iron-dependent cell death through a newly identified mitochondrial pathway.

Research Paper
Jun 20, 2026 0
Cholesterol Drug Bempedoic Acid Activates Key Fat-Burning Pathway in Liver Cells
Metabolic Health

Cholesterol Drug Bempedoic Acid Activates Key Fat-Burning Pathway in Liver Cells

New research reveals how the cholesterol medication bempedoic acid directly activates PPARα, boosting fat metabolism beyond its known effects.

Research Paper
Mar 29, 2026 3
CHKA Enzyme Drives Diabetic Blood Vessel Damage Through NAD+ Pathway
Metabolic Health

CHKA Enzyme Drives Diabetic Blood Vessel Damage Through NAD+ Pathway

New research identifies choline kinase alpha as a key driver of diabetic retinopathy and microvascular dysfunction.

Research Paper
Apr 3, 2026 0
Tirzepatide Cuts Key Inflammation Markers by Up to 34% in Meta-Analysis
Metabolic Health

Tirzepatide Cuts Key Inflammation Markers by Up to 34% in Meta-Analysis

A systematic review of 8 studies finds tirzepatide significantly reduces hsCRP and IL-6 across all doses and populations.

Research Paper
May 30, 2026 0
Smart Hydrogel Plus Stem Cell Exosomes Accelerate Diabetic Wound Healing
Metabolic Health

Smart Hydrogel Plus Stem Cell Exosomes Accelerate Diabetic Wound Healing

A dual-action therapy combining a glucose-responsive hydrogel with stem cell exosomes dramatically speeds diabetic wound closure in mice.

Research Paper
Apr 23, 2026 0
Scientists Discover Metabolic Weakness That Could Eliminate Aggressive Leukemia Cells
Metabolic Health

Scientists Discover Metabolic Weakness That Could Eliminate Aggressive Leukemia Cells

Researchers found a dual-target approach that selectively destroys the most treatment-resistant form of acute myeloid leukemia.

Research Paper
Mar 29, 2026 3
Aging and Western Diet Team Up to Sabotage Liver Thyroid Hormone Signaling
Metabolic Health

Aging and Western Diet Team Up to Sabotage Liver Thyroid Hormone Signaling

A mouse study reveals how aging and poor diet synergistically disrupt liver thyroid hormone metabolism, accelerating fatty liver disease — and why resmetirom may help.

Research Paper
Jun 24, 2026 0
Inclisiran Shows Promise for Treating High Cholesterol in Children
Metabolic Health

Inclisiran Shows Promise for Treating High Cholesterol in Children

New research examines whether the cholesterol-lowering drug inclisiran could benefit pediatric patients with genetic high cholesterol.

Research Paper
Mar 29, 2026 0
Semaglutide protects liver through direct action on blood vessel cells, not weight loss
Metabolic Health

Semaglutide protects liver through direct action on blood vessel cells, not weight loss

New research reveals semaglutide's liver benefits work independently of weight loss through specialized liver blood vessel cells.

Research Paper
Apr 16, 2026 0
Page 1 of 2Next